An "ultra-sensitive" new blood test can predict if breast cancer will return years before the disease shows up on scans, with 100% accuracy in determining relapse.
The test detected cancer on average 15 months before symptoms or scan results, with the earliest detection happening 41 months before confirmation, aiding in early intervention.
Collection
[
|
...
]